This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
From 2017 to 2023, the percentage of all opioid treatment programs offering 3 forms of medication for opioid use disorder (OUD) increased from 33% to 45%, but there is still a need to expand the offerings of OUD therapy across treatment programs. 1 Data from 10,289 facility-year observations were used, with 1211 in 2017 and 1421 in 2023.
Approximately 31% of people in the United States were overweight and 42% were obese in 2017 to 2018, compared with 34% and 30.5% " Obesity has risen considerably over the past 3 years, according to data from the Pew Research Center. in 1999 to 2000, respectively.
2017 Oct 10;17(1):230. National Institute on Aging. August 24, 2021. Accessed July 18, 2025. Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? a systematic review of definitions. BMC Geriatr. doi: 10.1186/s12877-017-0621-2. Newsletter Pharmacy practice is always changing.
Red raspberry leaves are rich in tannins (a chemical compound) and flavonoids (a plant pigment), which both have antioxidant properties, according to research in Antioxidants journal. A 2017 study demonstrated that ellagic acid can inhibit pancreatic cancer growth. But what about the leaves?
The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release.
SHOW MORE The FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma. The phase 3 ECHO trial showed significant progression-free survival improvement with acalabrutinib, supporting its approval as a new standard of care for untreated MCL.
One study conducted in 2016-2017 found that 10% of new prescriptions for contraceptive pills and patches were written by pharmacists during that period. 1 Meredith also cited promising outcomes from states like Oregon.
A new drug application for lorundrostat is expected to be filed with the FDA in 2025. Am J Prev Med 2017; 53:S172-S181. The most frequent dose limiting adverse effect is hyperkalemia which is dose-related with an incidence of 5% to 7%. mg/d, 1 mg/d, 2 mg/d, and placebo for 12 weeks. 17 The placebo-subtracted reductions in sBP were 8.1
J Clin Pharm Ther. 2021;46(5):1254-1262. doi:10.1111/jcpt.13419 13419 Gardenhire DS, Burnett D, Strickland S, Myers TR. A guide to aerosol delivery devices for respiratory therapists. American Association for Respiratory Care. Accessed June 6, 2025. link] Bosnic-Anticevich S, Bakerly ND, Chrystyn H, Hew M, van der Palen J. Patient Prefer Adherence.
Between 2017 and 2021, GLP-1 use increased 40-fold, as Indiana University School of Medicine statistics show an estimated 6 million US patients are now on semaglutide (Ozempic) or tirzepatide (Mounjaro). 5 Now, however, researchers are uncovering even further benefits of GLP-1RAs that reach beyond improved cardiometabolic outcomes.
Semi-synthetic opioids are scientifically modified versions of these naturally occurring compounds. The Food and Drug Administration (FDA) has approved certain opioids for: Relief of mild to moderate severe pain (e.g., The Food and Drug Administration (FDA) has approved certain opioids for: Relief of mild to moderate severe pain (e.g.,
In the 2017 book The Big Picture , author Sean Carroll seamlessly blends the scientific with the philosophical and comments that “life is not a substance, like water or rock; it’s a process, like fire or a wave crashing on the shore. Potential Roles of the Oncology Pharmacist My friend died of his metastatic cancer in early 2025.
million global deaths recorded in 2017. Updated October 16, 2017. The data, which were published in Nephrology , also highlighted comparable safety among the 2 treatments. The global prevalence is estimated to be about 11% to 13%, with 697.5 million cases of all-stage disease CKD and 1.2 ClinicalTrials.gov identifier: NCT02044653.
Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. The study found no significant differences in biosimilar use by age, race, or ethnicity, but regional variations existed.
from 2017 to 2020. Children today are less active than they used to be—and they’re also facing an increased amount of stress.” In recent history, childhood obesity statistics have indeed been alarming, with the US prevalence of youth-related obesity at 19.7%
The FDA approved a label expansion for glecaprevir/pibrentasvir (Mavyret) to treat acute hepatitis C virus (HCV) infection in patients 3 years of age and older with compensated cirrhosis or without cirrhosis, AbbVie announced in a release. 3 READ MORE: Infectious Disease Resource Center Pharmacy practice is always changing.
Updated July 14, 2017. If the bites worsen or signs of infection develop, if symptoms persist beyond a week, or if there are concerns about allergic reactions or fevers, he may need to visit a health care provider. 6 REFERENCES 1. Sun protection factor (SPF). Accessed May 12, 2025. Sunburn: treatment and prevention. Healthchildren.org.
2017 Sep;40(9):1273-1284. Published online June 09, 2025. doi:10.1001/jamainternmed.2025.1580 2025.1580 2. de Boer IH, Bangalore S, Benetos A, et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association. Diabetes Care. doi: 10.2337/dci17-0026. PMID: 28830958.
Between January 2015 and September 2017, monthly drug overdose deaths increased steadily but plateaued from September 2017 to September 2019. The study authors said that the 12-month moving sum of the drug overdose death rate ranged from 14.54 per 100,000 population in January 2015 to a peak of 33.24 in August 2023.
The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed. of the global market, valued at $39.3bn.
2 Not as prominent, urticaria was reported to impact 86 million people in 2017, which was around 1.1% Of the allergic-related skin diseases, AD is one of the most prominent, impacting more than 204 million people globally, or 2.6% of the population. of the population.
A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the organisation developing it. . A second is underway in 100 subjects and if positive could result in a green light for the therapy in 2023.
The company said it plans to present data at an upcoming medical meeting and will include it in filings with the FDA and regulators in Europe. Radioligand therapy combines a targeting compound that binds to markers expressed by tumours with a radioactive isotope.
Although some psychedelics have a long history in traditional medicine, regulatory agencies must evaluate psychedelic compounds the same way they assess any other drug. Psychedelic compounds are assessed by regulators the same way as any other drug. This US pathway offers early-phase benefits, including greater FDA collaboration.
Solving this before the clinical stage ensures the viability of compounds…” Addressing bioavailability challenges in the first phases of development is essential to help create the most robust product profile and increase the potential for success as small molecule drugs move to the clinic. amorphous solid dispersions, or ASDs.
The term ‘psychedelic treatments’ incorporates a broad spectrum of different compounds, from LSD, psilocybin and DMT, to MDMA, ibogaine and ketamine. The latter compound has already been approved for treatment-resistance depression as the product Spravato (esketamine), after being developed by Janssen.
Supporting the successful compounding of drugs with 3D printing processes has the potential to not only fulfil unmet patient needs but also drive efficiencies in hospital pharmacies. 2 The first drug produced through printing technology based on inkjet on powder was approved by the US FDA in 2015.
A 2017 review of studies found that guava may help treat or manage medical conditions like diabetes, gastrointestinal infections, and other infectious diseases. Guava Guava is a tropical fruit that is rich in fiber, vitamin C, and numerous phytonutrients. Still, more research needs to be done to confirm these benefits. For example, 1.5
Although Ozempic has been approved by the Food and Drug Administration (FDA) since 2017, its status as a household name is relatively recent. Weight loss is an off-label , non-FDA-approved use for Ozempic. The FDA has urged consumers to use caution when taking medication from these compound pharmacies.
With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. This has been demonstrated recently with PLUVICTO ® , which was the first US Food and Drug Administration (FDA)-approved targeted radioligand therapy for eligible patients with prostate cancer.
In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. 3 Is two too few? 3 Is two too few?
However, the FDA's approval of Lumakras for metastatic non-small cell lung cancer in May last year has a global analyst consensus sales forecast of $336m for this year, according to GlobalData’s Drugs Database. Amgen reported only a marginal 2.2% YoY revenue growth to $26.0bn last year.
Alnylam temporarily halted a phase 2 trial in 2017 after a blood clot killed a patient but research resumed in late 2017 after the FDA and Alnylam agreed on new clinical risk mitigation measures. The safety events were perhaps compounded by COVID19, which has been associated with abnormal blood clotting in some serious cases.
NMR relaxation methods distinguish between components (phases or compounds) that have different molecular mobilities For monoclonal antibodies, identification methodologies can employ chromatography, spectroscopy, isoelectric focusing, capillary electrophoresis and peptide mapping techniques. of Pharm Sci, 2017; 106(7), 1828-1838.
Though a 2017 literature review concluded there was no scientific evidence that inhaling hot and humidified air was helpful in relieving congestion caused by the common cold, Dr. Garcia-Ibáñez says steam helps humidify the nasal mucosa, and the more hydrated your secretions, the less nasal congestion you’ll experience.
In addition to Skyrizi’s recent supplementary CD indication, both Tremfya and Skyrizi received US FDA approval in psoriasis in 2017 and in 2019, respectively. These developments were compounded by Lilly’s announcement that it has discontinued development of mirikizumab for psoriasis in April of last year.
Berberine is a yellow alkaloid compound extracted from several plants such as goldenseal, Oregon grape, and tree turmeric. Beyond that, berberine isn’t as effective for weight loss as methods approved by the Food & Drug Administration (FDA). Does berberine help with weight loss?
Originally granted approval in its largest market, the US, in 2017, Ozempic has subsequently obtained approval for three distinct dosages, 0.5mg, 1.0mg, and 2.0mg, for the treatment of type 2 diabetes. This represents a significant 83% increase in sales between 2022–2029, demonstrating a compound annual growth rate (CAGR) of 9%.
Phenylephrine In September 2023, the FDA announced that a common decongestant found on shelves, phenylephrine, is not actually effective to decrease congestion. Some studies suggest curcumin, the active compound in turmeric, may even have antiviral properties. Here’s what to skip. or make an anti-inflammatory chicken soup.
Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. Since losing exclusive rights in 2017, Pfizer undertook an over-the-counter switching strategy to guard against revenue loss.
In fact, a 2007 study found that about 50 percent of people with hypothyroidism have SIBO, while a 2017 study found that levothyroxine use can contribute to the development of SIBO! A 2017 study also tied the use of levothyroxine to SIBO — however, I’m not sure if this is a chicken or egg thing… (2). Published 2017 Jun 30.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content